Evidence mapPaperPMID 41565878Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Analysis of the use of trade names versus active ingredient names using the example of acetylsalicylic acid and Aspirin® in the Frankfurter Allgemeine Zeitung.

Emma Krug, Roland Seifert

Abstract read
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emma KrugInstitute of Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Roland SeifertInstitute of Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. seifert.roland@mh-hannover.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Frankfurter Allgemeine Zeitung (F.A.Z.) is one of the most important national daily newspapers in Germany and serves as a source of information for more than 818,000 readers every day. The newspaper has high journalistic standards, which is why it should be assumed that pharmacological content is also presented correctly. Specifically, the differentiation between trade names and active ingredient names of drugs should be correct to inform readers, avoid surreptitious advertising and contribute to drug therapy safety. In this study, 345 articles from 2014 to 2023 from the online archive of the Frankfurter Allgemeine Zeitung were analyzed regarding the correct use of trade names using the example of Aspirin®. If the trade name is used incorrectly, suggestions are made to improve journalism about pharmacological content in the long term. The study shows that the trade name is used many times more frequently in the articles analyzed than the active ingredient name. In addition, the trade name is repeatedly mentioned in contexts where there is no need for it. This analysis shows that even in a renowned newspaper, mistakes are made in the correct naming of drugs. On this basis, further trade names and newspapers should be analyzed to counteract the "genericide" of drug names. The use of generic drug names is important for drug therapy safety.

Indexed as

AspirinNewspapers as TopicTerminology as TopicBulk DrugsGermanyHumansAspirinBulk DrugsAcetylsalicylic acidActive ingredient nameAspirin®Drug safetyFrankfurter Allgemeine ZeitungTrade name

Identifiers

PMID41565878
PMCPMC13152897

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.